cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
K-Number: K240867 · 2025-02-11
Device Summary
Frequently Asked Questions
What is the cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?
cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is a medical device that received FDA 510(k) clearance on 2025-02-11. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K240867.
When was cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems approved by the FDA?
cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems received FDA 510(k) clearance on 2025-02-11, under approval number K240867.
What company makes cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?
cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?
The FDA product code for cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is QQX.
Related Clinical Trials
Other Devices by Roche Molecular Systems, Inc.
Related Devices (Code: QQX)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.